Deborah Goldstein

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial

Martin Markowitz, Ian Frank, Robert M. Grant et al. · The Lancet HIV · 2017 · 217 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol

Justin D. Arnold, Eleanor Sarkodie, Megan Coleman et al. · The Journal of Sexual Medicine · 2016 · 75 citations

Medicine, Endocrinology, Gynecology +13

Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults

Katherine Banks, Mabel Kyinn, Shalem Leemaqz et al. · Hypertension · 2021 · 73 citations · Full text

Social Sciences, Endocrinology, Gender Studies +8

Evolocumab in HIV-Infected Patients With Dyslipidemia

Franck Boccara, Princy Kumar, Bruno Caramelli et al. · Journal of the American College of Cardiology · 2020 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17